Complications of radiation treatment in the sexual area in prostate cancer

Authors

  • Luis Enrique Pérez Moreno Hospital Universitario “Celestino Hernández Robau”
  • Lissi Lisbet Rodríguez Rodríguez Hospital Universitario “Celestino Hernández Robau”
  • Angela Gallo Favelo Hospital Universitario “Celestino Hernández Robau”
  • Juana María Pérez Villarreal Hospital Universitario “Celestino Hernández Robau”

Keywords:

prostatic neoplasms/radiotherapy, radiation effects

Abstract

A descriptive retrospective study was conducted to evaluate the efficacy of radiotherapy, emphasizing in the complications in the sexual area in patients with prostate cancer who were diagnosed in the municipality of Placetas and referred to the Service of Oncologic Urology of the Dr. Celestino Hernández Robau University Hospital from January 2003 to December 2010. The totality of the universe of 93 patients was selected, after informed consent. A survey was conducted, which included socio-demographic variables, as well as a sexuality questionnaire. The medical records were reviewed to assess the treatment. The main results showed there was a prevalence of the age group over 70 years, the white race, the histological type, and adenocarcinoma. The cancer history in the family prevailed and the specific prostatic antigen was an important diagnostic method. There was a prevalence of acute radiodermatitis and late radiation cystitis as major complications. The disorders in the sexual sphere were found in a small percentage of patients, being impotence the most frequent one. The effectiveness of treatment was confirmed, with low incidence of complications the sexual area.

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Pérez Moreno LE, Rodríguez Rodríguez LL, Gallo Favelo A, Pérez Villarreal JM. Complications of radiation treatment in the sexual area in prostate cancer. Acta Méd Centro [Internet]. 2013 Jan. 6 [cited 2025 Jul. 2];7(1):112-6. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/204

Issue

Vol. 7 No. 1 (2013): January-March

Section

Oncology

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).